Skip to main content

Adverse Reactions under Intermittent Rifampicin Regimens

  • Chapter
Pharmacology of Antibiotics

Part of the book series: Chemotherapy ((CT,volume 4))

Summary

Adverse reactions to rifampicin under intermittent regimens are more frequent with high 1200 mg doses of rifampicin than with low 600 mg doses. The incidence of adverse reactions was noted in 25% out of 324 patients being studied. It was with 6% during the low dosage and 28% with higher doses of rifampicin given intermittently. Termination of treatment due to toxicity to rifampicin was necessary in 1% and 10% respectively. The adverse reactions were of variable form and intensity. Five types of adverse reaction syndromes were encountered. The frequency of adverse reactions in intermittent therapy depends on many factors such as preceding daily therapy, size of dosage, group of patients, their state and clinical conditions. It can be accepted that they are immunologically induced.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Press, New York

About this chapter

Cite this chapter

Zierski, M. (1976). Adverse Reactions under Intermittent Rifampicin Regimens. In: Williams, J.D., Geddes, A.M. (eds) Pharmacology of Antibiotics. Chemotherapy, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3123-0_55

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3123-0_55

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3125-4

  • Online ISBN: 978-1-4684-3123-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics